About 1 result found for searched term "Regdanvimab" (0.631 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M25166 | Regdanvimab | Anti-infection |
| CT-P59 | ||
| Regdanvimab (CT-P59) is a human monoclonal antibody that targets the receptor-binding domain of SARS-CoV-2 spike protein, blocking interaction with ACE2 for viral entry. Regdanvimab can be used for the research of COVID-19. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
